Claude discovers a novel enzyme system with CRISPR-like repeats

Anthropic’s life sciences team reports that Claude autonomously identified a previously uncharacterized enzyme system with CRISPR-like DNA repeat patterns, suggesting AI can materially accelerate early-stage biological discovery. For CIOs and technology leaders, this is a signal that agentic AI is moving beyond productivity use cases into scientific R&D workflows, creating strategic opportunities for organizations with data-intensive research pipelines to shorten discovery cycles, uncover new IP, and build new AI-human operating models. It also implies IT organizations will need stronger foundations for secure large-scale data access, experiment orchestration, governance, and compute-intensive AI platforms to support regulated, high-impact research.